Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More
Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More
Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with… Read More
Astellas Pharma, a Japanese pharmaceutical and biotechnology company, is acquiring Seattle biotech Universal Cells. Astellas will pay up to $102.5… Read More
Seattle Genetics, the maker of cancer drug Adcetris, beat analyst expectations by a noticeable margin in its third-quarter earnings, reported… Read More
The Seattle Children’s Research Institute announced Wednesday that it has licensed a new gene therapy technology to Cambridge, Mass.,-based biotech company… Read More
Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development… Read More
A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio,… Read More
Kirkland, Wash.-based startup Cardiac Insight has raised an additional $4.5 million to bolster production and distribution of its lightweight disposable… Read More
Seattle’s Juno Therapeutics, a biotech company developing cutting edge CAR T immunotherapies for cancer, faces a narrow field of competitors. Few… Read More
Seattle-based biotech company Juno Therapeutics beat analyst expectations in its second quarter revenue Thursday, reporting $21.3 million in revenue for… Read More
Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries… Read More
